Go to Page # Page of 28

PetVivo Holdings, Inc.

 Wesley C. Hayne, John Lai, Randy Wenthold, Cynthia Sweatt, David Deming, David Merrill, David B. Mas
Description: Kush™ product offers significant benefits for the management of pain over NSAIDs which are the existing standard of care but have side effects, require monitoring and are often not well tolerated.
Views: 7648
Domain: Medical
Category: Veterinary
Contributing Organization: PetVivo Holdings, Inc.
 ‐ More of their Presentations
weSRCH App on Apple
PetVivo Holdings, Inc.
Corporate Presentation
April 2018

This presentation and the accompanying oral commentary contains forward-looking statements within the meaning
of the federal securities laws, which statements are subject to substantial risks and uncertainties that could cause
actual results to differ materially from those anticipated or projected by the forward- ... See more

Recent Presentations

Yalin Firinci
19 August, 2019

Regulatory Science for R&D Promotion

At present, the nation’s policy for Research and Development (R&D) promotion of innovative pharmaceuticals & improvement of environments for the R&D is formulated by Japanese gover

18 August, 2019
16 August, 2019